We previously demonstrated the broad and predictive utility of murine OX40-specific immuno-PET radiotracers, which enabled early detection of cancer via vaccine-induced T-cell responses (21,28) and early allogeneic immune responses preceding transplant complications in mice (22). This evidence concerns the gene TNFRSF4 and cancer.